FORUM MARKETS INC (FRMM) Fundamental Analysis & Valuation

NASDAQ:FRMM • US68236V4014

Current stock price

2.75 USD
-0.06 (-2.14%)
At close:
2.74 USD
-0.01 (-0.36%)
After Hours:

This FRMM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. FRMM Profitability Analysis

1.1 Basic Checks

  • In the past year FRMM has reported negative net income.
  • In the past year FRMM has reported a negative cash flow from operations.
  • In the past 5 years FRMM always reported negative net income.
  • In the past 5 years FRMM always reported negative operating cash flow.
FRMM Yearly Net Income VS EBIT VS OCF VS FCFFRMM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • FRMM has a Return On Assets of -23.10%. This is in the better half of the industry: FRMM outperforms 73.69% of its industry peers.
  • FRMM has a Return On Equity of -52.37%. This is in the better half of the industry: FRMM outperforms 62.48% of its industry peers.
Industry RankSector Rank
ROA -23.1%
ROE -52.37%
ROIC N/A
ROA(3y)-229.08%
ROA(5y)-148.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRMM Yearly ROA, ROE, ROICFRMM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FRMM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRMM Yearly Profit, Operating, Gross MarginsFRMM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

4

2. FRMM Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for FRMM has been increased compared to 1 year ago.
  • FRMM has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, FRMM has an improved debt to assets ratio.
FRMM Yearly Shares OutstandingFRMM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K
FRMM Yearly Total Debt VS Total AssetsFRMM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • FRMM has an Altman-Z score of -0.55. This is a bad value and indicates that FRMM is not financially healthy and even has some risk of bankruptcy.
  • FRMM has a Altman-Z score of -0.55. This is comparable to the rest of the industry: FRMM outperforms 56.67% of its industry peers.
  • A Debt/Equity ratio of 1.11 is on the high side and indicates that FRMM has dependencies on debt financing.
  • The Debt to Equity ratio of FRMM (1.11) is worse than 76.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Altman-Z -0.55
ROIC/WACCN/A
WACCN/A
FRMM Yearly LT Debt VS Equity VS FCFFRMM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • FRMM has a Current Ratio of 10.07. This indicates that FRMM is financially healthy and has no problem in meeting its short term obligations.
  • FRMM has a better Current ratio (10.07) than 79.88% of its industry peers.
  • FRMM has a Quick Ratio of 10.07. This indicates that FRMM is financially healthy and has no problem in meeting its short term obligations.
  • FRMM's Quick ratio of 10.07 is amongst the best of the industry. FRMM outperforms 80.08% of its industry peers.
Industry RankSector Rank
Current Ratio 10.07
Quick Ratio 10.07
FRMM Yearly Current Assets VS Current LiabilitesFRMM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

0

3. FRMM Growth Analysis

3.1 Past

  • The earnings per share for FRMM have decreased strongly by -204.39% in the last year.
EPS 1Y (TTM)-204.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRMM Yearly Revenue VS EstimatesFRMM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M 8M 10M
FRMM Yearly EPS VS EstimatesFRMM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -1K -2K -3K

0

4. FRMM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FRMM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FRMM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRMM Price Earnings VS Forward Price EarningsFRMM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRMM Per share dataFRMM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. FRMM Dividend Analysis

5.1 Amount

  • No dividends for FRMM!.
Industry RankSector Rank
Dividend Yield 0%

FRMM Fundamentals: All Metrics, Ratios and Statistics

FORUM MARKETS INC

NASDAQ:FRMM (4/2/2026, 8:27:44 PM)

After market: 2.74 -0.01 (-0.36%)

2.75

-0.06 (-2.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners23.24%
Inst Owner ChangeN/A
Ins Owners20.7%
Ins Owner ChangeN/A
Market Cap52.28M
Revenue(TTM)4.11M
Net Income(TTM)-233.12M
Analysts82.86
Price TargetN/A
Short Float %22.62%
Short Ratio7.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.72
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-136.67
EYN/A
EPS(NY)-3.06
Fwd EYN/A
FCF(TTM)-1.02
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS0.22
BVpS23.42
TBVpS23.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.1%
ROE -52.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-229.08%
ROA(5y)-148.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.07
Quick Ratio 10.07
Altman-Z -0.55
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-204.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.86%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year54.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3310.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.7%
OCF growth 3YN/A
OCF growth 5YN/A

FORUM MARKETS INC / FRMM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FORUM MARKETS INC (FRMM) stock?

ChartMill assigns a fundamental rating of 1 / 10 to FRMM.


Can you provide the valuation status for FORUM MARKETS INC?

ChartMill assigns a valuation rating of 0 / 10 to FORUM MARKETS INC (FRMM). This can be considered as Overvalued.


Can you provide the profitability details for FORUM MARKETS INC?

FORUM MARKETS INC (FRMM) has a profitability rating of 1 / 10.